Burning Rock Biotech Ltd. (BNR)
9.66
-0.14
(-1.43%)
USD |
NASDAQ |
Aug 26, 14:25
Burning Rock Biotech Debt to Equity Ratio : 0.0985 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0985 |
| December 31, 2025 | 0.0806 |
| September 30, 2025 | 0.0604 |
| June 30, 2025 | 0.0693 |
| March 31, 2025 | 0.074 |
| December 31, 2024 | 0.0901 |
| September 30, 2024 | 0.1557 |
| June 30, 2024 | 0.1592 |
| March 31, 2024 | 0.0265 |
| December 31, 2023 | 0.016 |
| September 30, 2023 | 0.0221 |
| June 30, 2023 | 0.0315 |
| March 31, 2023 | 0.0396 |
| December 31, 2022 | 0.0438 |
| September 30, 2022 | 0.0473 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.0508 |
| March 31, 2022 | 0.0468 |
| December 31, 2021 | 0.047 |
| September 30, 2021 | 0.049 |
| June 30, 2021 | 0.0624 |
| March 31, 2021 | 0.0626 |
| December 31, 2020 | 0.0194 |
| September 30, 2020 | 0.018 |
| June 30, 2020 | 0.0208 |
| March 31, 2020 | 0.0785 |
| December 31, 2019 | 0.1062 |
| September 30, 2019 | 0.0948 |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -37.07 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Myriad Genetics, Inc. | 0.6927 |
| BioRestorative Therapies, Inc. | 0.0114 |
| CareDx, Inc. | 0.0452 |
| Natera, Inc. | 0.1309 |
| Exagen, Inc. | 2.264 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 114.04M |
| Total Liabilities (Quarterly) | 39.28M |
| Shareholders Equity (Quarterly) | 74.76M |
| Current Ratio | 3.050 |
| Net Debt Paydown Yield | -0.03% |